- Quotation of the day: On Generalized Cost Effectiveness Analysis (GCEA)by Jason Shafrin (Healthcare Economist) on January 14, 2025
“I’d like to see Generalized Cost Effectiveness Analysis become the norm for how we assess value.” – Rep. Jake Auchincloss (D-MA 4th District) See the full interview here. To learn more about GCEA, check out the GCEA User Guide published […]
- Out of Pocket Costs for Follow-Up Tests After Abnormal Screening Mammogram and Their Impact on Breast Cancer Survivalby Jason Shafrin (Healthcare Economist) on January 14, 2025
Today, the American Cancer Society’s Cancer Action Network released a report titled “Out of Pocket Costs for Follow-Up Tests After Abnormal Screening Mammogram and Their Impact on Breast Cancer Survival.” The empirical analysis was conducted […]
- How big is the 2025 Medicare rate cut for physicians?by Jason Shafrin (Healthcare Economist) on January 10, 2025
At the end of last year, CMS finalized a rate cut for Medicare reimbursement to physicians. The CMS Fact Sheet states: …average payment rates under the PFS [Physician Fee Schedule] will be reduced by 2.93% in CY 2025, compared to the average […]
- Life sciences companies falling behind?by Jason Shafrin (Healthcare Economist) on January 9, 2025
That is what an analysis from PwC finds, at least with respect to stock market returns. Our PwC equal-weight index of 50 pharma companies analyzes the sector’s total shareholder returns performance relative to the S&P 500 Equal Weighted Index. […]
- When should we privatize government industries?by Jason Shafrin (Healthcare Economist) on January 8, 2025
Tyler Cowen is an economist from George Washington University and a libertarian. Thus, you would expect his answer to this question would be ‘always’. In a recent Bloomberg article discussing whether to privatize government assets (e.g., USPS), […]
- What is the PICOSI framework?by Jason Shafrin (Healthcare Economist) on January 7, 2025
When conducting evidence synthesis, many individuals use the PICO framework. PICO stands for population; intervention; comparator(s); and outcome. This helps to describe the research question that the evidence synthesis aims to answer. However, […]
- Weekend Linksby Jason Shafrin (Healthcare Economist) on January 5, 2025
Emily Oster on the power of nuance in public health. When did sustained economic growth begin? NYT: Rethinking drinking? Lex Fridman interviews Javier Milei (en español). Dumbest state “law” of the month
- My Publications in 2024by Jason Shafrin (Healthcare Economist) on January 3, 2025
Here is the list of my papers that were published in 2024. Manuscripts were published in Value in Health, BMJ Open, Journal of Comparative Effectiveness Research, Forum for Health Economics and Policy, Annals of the American Thoracic Society and […]
- China’s transition to DRG-based hospital reimbursementby Jason Shafrin (Healthcare Economist) on January 2, 2025
China has been transitioning from a fee-for-service (FFS) payment system to a Diagnosis-Related Group (DRG) payment system for hospitals in various cities. Under the FFS model, hospitals were reimbursed for each individual healthcare service […]
- How will AI change health care in 2025?by Jason Shafrin (Healthcare Economist) on January 1, 2025
To answer this question, I of course asked different AIs what the answer would be. Their responses: ChatGPT. In 2025, AI will significantly enhance healthcare by improving diagnostic accuracy, such as detecting early-stage cancers through tools like […]